Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atsushi Satake

Showing results (51-60 of 84) with videos related to

Pageof 9
Sort By:
Case Reports in Oncology|November 10, 2017
Transplant-Ineligible Symptomatic but Indolent Multiple Myeloma Shows Better Prognosis with Conventional AgentsAya Nakaya, Shinya Fujita, Atsushi Satake, et al.
Frontiers in Nutrition|September 7, 2018
Combined Use of Ninjin'yoeito Improves Subjective Fatigue Caused by Lenalidomide in Patients With Multiple Myeloma: A Retrospective StudyTomoki Ito, Akiko Konishi, Yukie Tsubokura, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 20, 2022
Real-world efficacy of letermovir prophylaxis for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation: A single-center retrospective analysisHideaki Yoshimura, Atsushi Satake, Yuka Ishii, et al.
Acta Medica Okayama|October 26, 2016
Phase I/IIa Study of Low Dose Subcutaneous Interleukin-2 (IL-2) for Treatment of Refractory Chronic Graft Versus Host DiseaseTakeru Asano, Ken-Ichi Matsuoka, Satoshi Iyama, et al.
Leukemia Research Reports|June 14, 2019
Retrospective analysis of adolescent and young adult with lymphoma at two cancer facilities in JapanAya Nakaya, Shinya Fujita, Atsushi Satake, et al.
Leukemia Research Reports|June 14, 2019
Neutrophil-to-lymphocyte ratio (NLR) fails to predict outcome of diffuse large B cell lymphomaYoshiko Azuma, Aya Nakaya, Shinya Fujita, et al.
Leukemia Research Reports|March 27, 2019
Evaluation of eltrombopag in patients with aplastic anemia in real-world experienceAkiko Konishi, Aya Nakaya, Shinya Fujita, et al.
Oncology Letters|January 23, 2020
Evaluation of azacitidine in patients with transplant-ineligible myelodysplastic syndromes and acute myeloid leukemia with myelodysplasia-related changes in a Japanese clinical settingAya Nakaya, Shinya Fujita, Atsushi Satake, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 7, 2018
[Successful treatment with brentuximab vedotin maintenance therapy after autologous stem cell transplantation in high-risk Hodgkin lymphoma]Kazuyoshi Ishii, Yoshiko Azuma, Akiko Konishi, et al.
Arthritis Research & Therapy|November 10, 2020
Mycophenolic acid, the active form of mycophenolate mofetil, interferes with IRF7 nuclear translocation and type I IFN production by plasmacytoid dendritic cellsMinoru Shigesaka, Tomoki Ito, Muneo Inaba, et al.
Pageof 9

Showing results (51-60 of 84) with videos related to

Sort By:
Pageof 9
Case Reports in Oncology|November 10, 2017
Transplant-Ineligible Symptomatic but Indolent Multiple Myeloma Shows Better Prognosis with Conventional AgentsAya Nakaya, Shinya Fujita, Atsushi Satake, et al.
Frontiers in Nutrition|September 7, 2018
Combined Use of Ninjin'yoeito Improves Subjective Fatigue Caused by Lenalidomide in Patients With Multiple Myeloma: A Retrospective StudyTomoki Ito, Akiko Konishi, Yukie Tsubokura, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 20, 2022
Real-world efficacy of letermovir prophylaxis for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation: A single-center retrospective analysisHideaki Yoshimura, Atsushi Satake, Yuka Ishii, et al.
Acta Medica Okayama|October 26, 2016
Phase I/IIa Study of Low Dose Subcutaneous Interleukin-2 (IL-2) for Treatment of Refractory Chronic Graft Versus Host DiseaseTakeru Asano, Ken-Ichi Matsuoka, Satoshi Iyama, et al.
Leukemia Research Reports|June 14, 2019
Retrospective analysis of adolescent and young adult with lymphoma at two cancer facilities in JapanAya Nakaya, Shinya Fujita, Atsushi Satake, et al.
Leukemia Research Reports|June 14, 2019
Neutrophil-to-lymphocyte ratio (NLR) fails to predict outcome of diffuse large B cell lymphomaYoshiko Azuma, Aya Nakaya, Shinya Fujita, et al.
Leukemia Research Reports|March 27, 2019
Evaluation of eltrombopag in patients with aplastic anemia in real-world experienceAkiko Konishi, Aya Nakaya, Shinya Fujita, et al.
Oncology Letters|January 23, 2020
Evaluation of azacitidine in patients with transplant-ineligible myelodysplastic syndromes and acute myeloid leukemia with myelodysplasia-related changes in a Japanese clinical settingAya Nakaya, Shinya Fujita, Atsushi Satake, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 7, 2018
[Successful treatment with brentuximab vedotin maintenance therapy after autologous stem cell transplantation in high-risk Hodgkin lymphoma]Kazuyoshi Ishii, Yoshiko Azuma, Akiko Konishi, et al.
Arthritis Research & Therapy|November 10, 2020
Mycophenolic acid, the active form of mycophenolate mofetil, interferes with IRF7 nuclear translocation and type I IFN production by plasmacytoid dendritic cellsMinoru Shigesaka, Tomoki Ito, Muneo Inaba, et al.
Pageof 9